Healio

Evolocumab lowers risk for first major cardiovascular events

Please provide your email address to receive an email when new articles are posted on . Evolocumab is the first PCSK9 inhibitor to demonstrate effectiveness in primary and secondary prevention ...
AOL

What does Repatha cost with Medicare?

Most stand-alone Medicare Part D prescription drug plans and Medicare Advantage plans that include drug coverage cover Repatha, an injectable medication for high cholesterol and cardiovascular disease ...
Healio

Repatha made available via direct-to-patient program at discounted price

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...
WRAL

Experimental daily pill may lower cholesterol in patients who don’t see enough benefit with statins alone, study finds

In the United States, evolocumab injection already has been approved by the FDA. The medication is indicated to reduce the risk of heart attack and stroke in adults with established cardiovascular ...
Medscape

FDA Approves Once-Monthly Cholesterol-Lowering Evolocumab (Repatha) Device

BETHESDA, MD — The US Food and Drug Administration (FDA) has approved the evolocumab (Repatha, Amgen) Pushtronex system, the first once-monthly delivery option for a proprotein convertase subtilisin ...
KTBS

Experimental daily pill may lower cholesterol in patients who don’t see enough benefit with statins alone, study finds

One group received evolocumab injections under the skin every two weeks while the other group received injections of a placebo every two weeks. The data showed that, after an average of 4.6 years, ...